Operating Income: The income after operating expenses.
Cue Biopharma, Inc. (CUE) had Operating Income of $-87.69M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$7.88M |
|
$-153.07M |
|
-- |
|
$7.88M |
|
$95.57M |
|
|
Operating Income |
$-87.69M |
$-65.37M |
|
$-153.07M |
|
$-153.07M |
|
$-153.07M |
|
$-153.07M |
|
$-153.07M |
|
$-153.07M |
|
$-87.69M |
|
$-87.66M |
|
6.34M |
|
6.34M |
|
$-24.14 |
|
$-24.14 |
|
| Balance Sheet Financials | |
$26.62M |
|
$0.26M |
|
$4.08M |
|
$30.71M |
|
$21.22M |
|
-- |
|
$7.18M |
|
$28.40M |
|
$2.31M |
|
$2.31M |
|
$2.31M |
|
5.23M |
|
| Cash Flow Statement Financials | |
$-39.95M |
|
$-0.12M |
|
$30.32M |
|
$27.29M |
|
$17.55M |
|
$-9.74M |
|
$23.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1113.31% |
|
-1113.31% |
|
-- |
|
-1943.21% |
|
-1943.21% |
|
$-40.07M |
|
-- |
|
-- |
|
-- |
|
0.26 |
|
-- |
|
1.46 |
|
61.44 |
|
-6626.28% |
|
-6626.27% |
|
-498.48% |
|
-6626.28% |
|
$0.44 |
|
$-6.32 |
|
$-6.30 |
|